CS245471B1 - Lead alloy with low antimony content - Google Patents
Lead alloy with low antimony content Download PDFInfo
- Publication number
- CS245471B1 CS245471B1 CS83716A CS71683A CS245471B1 CS 245471 B1 CS245471 B1 CS 245471B1 CS 83716 A CS83716 A CS 83716A CS 71683 A CS71683 A CS 71683A CS 245471 B1 CS245471 B1 CS 245471B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- anne
- lead alloy
- eme eme
- antimony content
- low antimony
- Prior art date
Links
- 229910000978 Pb alloy Inorganic materials 0.000 title claims 2
- 229910052787 antimony Inorganic materials 0.000 title claims 2
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 title claims 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 1
- QQHJESKHUUVSIC-UHFFFAOYSA-N antimony lead Chemical compound [Sb].[Pb] QQHJESKHUUVSIC-UHFFFAOYSA-N 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 claims 1
- 101100532679 Caenorhabditis elegans scc-1 gene Proteins 0.000 description 1
- 235000017399 Caesalpinia tinctoria Nutrition 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000388430 Tara Species 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
Landscapes
- Cell Electrode Carriers And Collectors (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Description
I -2-I -2-
Ha3BaHge- H3oópeTemiaHa3BaHge- H3oópeTemia
Cbhhbobuh cruiaB c hb3khm coflepacaHneM cypBMUCbhhbobuh cruiaB c hb3khm coflepacaHneM cypBMU
OdJiacTL npmeHeHM aaodpeTeHHfl Η3θόρβτβΗΗβ KacaeTCH οβηηπ;οβογο cruiasa c hh3khm co^epacameMCypSMU JUIX Η3Γ0Τ0ΒΠβΗΗΗ pemeTHaTHX imaCTHHOK jwch kecjiothuxCBHHIÍOBHX aKKyMyXHTOpOB.J θ L aca θ θ θ θ θ θ θ θ θ eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme eme
XapaKTepHCTHKa η3Βθοτηηχ tgxhhhockhx pemeHMt CBHHnoBne croiaBu c cosepacamieM cyptm ot 2 ao 8 % npzMe-HíHOT JWH Η3ΓΟΤΟΒΖΓβΗΗΗ aKKyiťiyjIHTOpHUX ρθΙΠβΤ0Κ.*Ιί3Ββ0ΤΗ0, ETOo nejma noBumeHHfl cpoxa cjqpcdH aKKywyjiHTopoB η οηηββηηηhx ctohmocth BHÓnpaioT B03M0BH0 Hti3Koe cojiepacaHHe CyptMH..CmíaB c. hh3khm coflepsaraeM cypBMU no cpaBHeHmo co craiasoM,coxepscaníHM 8 % cyptMH, βμθθτ HenocTaTKH, 3aKjncraaionmeca bHeánaronpilOTHUX ΛΕΤΘΗΗΗΧ CBOfiCTBaX H HeSOCTaTOEHOM Mexa- .mraecKoS προπΗοοτΗ owmrax H3 Hero ρβιπβτοκ. Ημθιοτοα ποπητκηKOMneHCnpOBaTB 3TH ΗβΛΟΟΤΒΤΚΗ ΠρΗΜΘΗβΗΗΘΜ ΛΟΠΟπΗΠΤβΛΒΗΗΧJierHpywix κομποηθητοβ. ΙΙθβθοτθη cbhhhobhK cmraB c hh3khm conepacainieM cypBMU ®ia·ε3γοτοβλόηκη pemeTHaTHX nziacniHOK pjix. aKyyMyáwTopoB, cosěp-·acanmS 0,5-6,5 % cyptMH, 0,3 - 2,5 % μιιιπβηκβ, ocTanBHoeCBHHen (BiwoKeHHoe onHcaHae η300ρθτθηηη ΦΕΓ κ ηκπθπτοΒθηηομ 245471 -3- 33ΛΒΚβ Jfc 1.193.253). 3το cnzaB HMeei HezocTaTOHHue ζπτθίΐΗΗβCBOftCTBa npH BHCOKOfi eKOpOCTH ZHTBH Η, B HOCTHOCTH, BUCOKyiOCKZOHHOCTB K ΟόρβΒΟΒΘΗΗΙΟ ΓΟρΗΗΗΧ ΤρβΠξΗΗ.XapaKTepHCTHKa η3Βθοτηηχ tgxhhhockhx pemeHMt CBHHnoBne croiaBu c cosepacamieM cyptm ot 2 and 8% npzMe HíHOT JWH-Η3ΓΟΤΟΒΖΓβΗΗΗ aKKyiťiyjIHTOpHUX ρθΙΠβΤ0Κ. * Ιί3Ββ0ΤΗ0, ETOO Nejma noBumeHHfl epoxy cjqpcdH aKKywyjiHTopoB η οηηββηηηhx ctohmocth BHÓnpaioT B03M0BH0 Hti3Koe cojiepacaHHe CyptMH..CmíaB c. Hh3khm coflepsaraeM cypBMU well as cpaBHeHmo craiasoM, coxepscaníHM 8% cyptMH, βμθθτ HenocTaTKH, 3aKjncraaionmeca bHeánaronpilOTHUX ΛΕΤΘΗΗΗΧ CBOfiCTBaX H HeSOCTaTOEHOM Mex-. THμθιοτοα ποπητκηKOMneHCnpOBaTB 3TH ΗβΛΟΟΤΒΤΚΗ ΠρΗΜΘΗβΗΗΘΜ ΛΟΠΟπΗΠΤβΛΒΗΗΧJierHpywix κομποηθητοβ. ΙΙθβθοτθη cbhhhobhK cmraB c hh3khm conepacainieM cypBMU ®ia · ε3γοτοβλόηκη pemeTHaTHX nziacniHOK pjix. aKyyMyáwTopoB, cosěp- · acanmS 0.5-6.5% cyptMH, 0.3 - 2.5% μιιιπβηκβ, ocTanBHoeCBHHen (BiwoKeHHoe onHcaHae η300ρθτθηηη ΦΕΓ ηκπθπτοΒθηηομμηημμ 245) 3το cnzaB HMeei HezocTaTOHHue CπτθίΐΗΗβCBOftCTBa npH BHCOKOfi eKOpOCTH ZHTBH Η, B HOCTHOCTH, BUCOKyiOCKZOHHOCTB K ΟόρβΒΟΒΘΗΗΙΟ ΓΟρΗΗΗΧ ΤρβΠξΗΗ.
Jfezee H3BecTHO Η3Γ0Τ0ΒζβΗΗθ pemeTMarax πζθότηηοκ H3 cbhh-ςοΒΟΓΟ cfuiaBa o hh3khm cozepzaHHeM cyptMU, cozepKamzA 0,5 - 3,5 % cyptMH, 0,025 - 0,3 % Munr&HKa, 0,005 - 0,1 % cezeHa,0,002 - 0,05 % ojiOBa, 0,01 - 0,1 % μθζη, ocTaziHoe CBímez(βηζοκθηηοθ onHcaHHe Η3θόρβτβΗΗπ ΦΕΓ κ HeaKnenTOBaHHoit3aaBKe 16 2.403.849). Η3ΒβΟΤβΗ ΤΘΚΚβ ΟΒΗΗΓζΟΒίώ CUZaB JtM npOB3BOflGTBa ρθΓΠβΤΗΟ-τυχ wiacTHHOK cbhhhobhx HKKyMyzzTopoB, cozepsamnÉ 1,0 - 3,5 $ cypBMH, 0,025 - 0,2 % MtraLHKa, 0,005 - 0,1 cezeHa,0,05 - 0,5 % ojiOBa, ocTazBHoe CBHHen (βηποκθηηοθ oimcaHHeH3oópeTeHHff TJIP κ aKneniOBaHHoň 3aaBKe Jé 119.439).Jfezee H3BecTHO Η3Γ0Τ0ΒζβΗΗθ pemeTMarax H3 cbhh-ςοΒΟΓΟ cfuiaBa hh3khm cozepzaHHeM cyptMU, cozepKamzA 0.5 - 3.5% cyptMH, 0.025 - 0.3% Munr & ojiOBa, 0.01 - 0.1% μθζη, ocTaziHoe CBimez (βηζοκθηηοθ onHcaHHe θ3θόρβτβΗΗπ ΦΕΓ κ HeaKnenTOBaHHoit3aaBKe 16 2.403.849). Η3ΒβΟΤβΗ ΤΘΚΚβ ΟΒΗΗΓζΟΒίώ CUZaB JtM npOB3BOflGTBa ρθΓΠβΤΗΟ-τυχ wiacTHHOK cbhhhobhx HKKyMyzzTopoB, cozepsamous 1.0 - 3.5 $ cypBMH, 0.025 - 0.2% MtraLHKa, 0.005 - 0.1 across, 0.05 - 0.5% ojiOBa, ocTazBHoe CBHHen (βηποκθηηοθ oimcaHHeH3oópeTeHHff TJIP κ aKneniOBaHHoň 3aaBKe Jé 119.439).
HejiocTaTOK sthx ciuiaBOB - nx ckzohhoctl k otípasoBamno ropm-hhx TpenfHH πρπ ΒΗοοκοϋ οκοροοτΗ zhtlh, b pe3yzBTaie aeroOrpaHHHHBaeTCH θφφβΚΤΗΒΗΟΟΤΒ- ΒΗΟΟΚΟΠΡΟΗ3ΒΟΖΗΤΒΖΒΗΗΧ ZHTeií-HHX ΗΒΤΟΜΒΤΟΒ H H6B03M0HH0 HCKOTHHTB ΠΟΖΥΗβΗΗβ ΖθΦθΚΤΗΗΧOTZHBOK. ΚροΜβ τογο, Ha3BaHHue cnzasu ημθκτ ηθζοοτβτοκ, πτο ohh πρπ ' QVXXBSSS CKZOHEH Κ' ΚΗΠΒΗΗΚ) Η ΗΗΤβ00ρ830ΒΗΗΗΚ). ΠθΟΖΘ 33ΖΠΒΚΗΖ03ΠρθΒΒΗΗΟΓΟ ΚΟΖΗΗΘΟΤΒΒ CHZaBa Β ΖΗΤΘΚΗγΚ φθρΜ7 Η ΙφβρΗ-ΒΘΗΗΗ ΖΗΤΘΚΗΟϋ CTpyH Ha CZHBHOM ΗβΖΟόβ ΟΠρΟΚΗΖΗΒΒΤβΖΗ OÓpa-3yroTCH KanzH η hhth. 3th ήβοτηηηο hzh hozhoctbto 3acTUBniHeKanzH hzh hhth, nazaa b czhbhoh xezod, dzoKHpyioT KaHazu zh-τβ&ίΟΗ φορΜΗ, BczezcTBné aero. npn pa3ZHBKe nozyaaioTca ze-φβΚΤΗΗβ pemeTKH, KOTOpue ΗβΖΒ3Η HCnOZBSOBaTB ZZH aKKyMyza-TOPOB. KanZH H HHTH, ΠΟΠΘΒΙΠΗβ Β ΖΗΤΘΗΗγίΟ φορΜγ, ΓφΗΒΟΖΗΤTarace κ noBpeatzeHHM czoa irpotíKOBux οπηζκοβ,. HaHeceHHoro naCTeHKy ΖΗΤβΗΗοϋ φορΜΗ, KOTOpaa, K3K Η3Ββ0ΤΗ0, CZyjKHT ΚΗΚ TenzoH30ZHpyionmS czo2 h iipezoTBpamaeT πρηζηπθηηθ otzhbkh b .: ΖΗΤβΗΗΟϋ φορΜβ. ΠΟ3ΤΟΜ3Γ CZOH npOÓKOBHX ΟΠΗΖΚΟΒ ΗβοόχΟΖΗΜΟ 245471 -4- 33Μ6ΗΠΤΒ ΠρθΒβθΒρθΜθΗΗΟ, ΗΤΟ ΠρΗΒΟΑίϊΤ Κ irp0H3B0flCTBSHHUMΠΟΤβρΒΜ.HejiocTaTOK sthx ciuiaBOB - nx ckzohhoctl k otípasoBamno ropm-hhx TpenfHH πρπ ΒΗοοκοϋ οκοροοτΗ zhtlh, b pe3yzBTaie-HHX ΗΒΤΟΜΒΤΟΒ H H6B03M0HH0 HCKOTHHTB ΠΟΖΥΗβΗΗβ ΖθΦθΚΤΗΗΧOTZHBOK. 3ροΜβ τογο, Ha3BaHHue cnzasu ημθκτ ηθζοοτβτοκ, πτο ohh πρπ 'QVXXBSSS CKZOHEH Κ' ΚΗΠΒΗΗΚ) Ηβ00ρ830ΒΗΗΗΚ). ΠθΟΖΘ 33ΖΠΒΚΗΖ03ΠρθΒΒΗΗΟΓΟ ΚΟΖΗΗΘΟΤΒΒ CHZaBa ΒγΚ φθρΜ7 ΗφβρΗ-ΒΘΗΗΗ ΖΗΤΘΚΗΟϋ CTpyH Ha CZHBHOM ΗβΖΟόβ βΠρΟΚΗΖΗΒΒΤβΖΗ Opa-3yroTCH KanzH η hhth. 3th ήβοτηηηο hzh hozhoctbto 3acTUBniHeKanzH hzh hhth, nazaa b czhbhoh xezod, dzoKHpyioT KaHazu zh-τβ & ίΟΗ φορΜΗ, BczezcTBné aero. npn pa3ZHBKe nozyaaioTca ze-φβΚΤΗΗβ pemeTKH, KOTOpue ΗβΖΒ3Η HCnOZBSOBaTB ZZH aKKyMyza-TOPOB. KanZH H HHTH, ΠΟΠΘΒΙΠΗβ Β Ογίφ φορΜγ, ΗΒΟΖΗΤφΗΒΟΖΗΤTarace κ noBpeatzeHHM czoa irpotíKOBux οπηζκοβ ,. HaHeceHHoro naCTeHKy ΖΗΤβΗΗοϋ φορΜΗ, KOTOpaa, K3K Η3Ββ0ΤΗ0, CZyjKHT ΚΗΚ TenzoH30ZHpyionmS czo2 h iipezoTBpamaeT πρηζηπθηηθ otzhbkh b.: ΖΗΤβΗΗΟϋ φορΜβ. ΠΟ3ΤΟΜ3Γ CZOH npOÓKOBHX ΟΠΗΖΚΟΒ ΗβοόχΟΖΗΜΟ 245471 -4- 33Μ6ΗΠΤΒ ΠρθΒβθΒρθΜθΗΗΟ, Π ΠρΗΒΟΑίϊΤ Κ irp0H3B0flCTBSHHUMΠΟΤβρΒΜ.
UejiB H3oópeTemifl : ΠβΛΒ 2300ρβΤβΗΗΗ 3aKJH0HaeTCH Β pa3padOTKe ΟΒΗΗΙξΟΒΟΓΟ ciraa-Ba c HB3KHM coflepxaHaeM cypBMH jyui η3γοτοβλθηεη pemena-thx raaoTUH.OK jvih khcjiothux cbhhhobhx aKKyMyjwTopoB, ko-TopuS odjia^aeT bucokoS ctokkootbio upothb odpaBOBamiH ro-panux τρβιΐξΐΐΗ npn bkcokoíí Teraiepaiype jbitm η οληοβρθμθηηοHCKJEKHaeT Kanamte a HHTeodpa3OBaHae.UejiB H3oópeTemifl: ΠβΛΒ 2300ρβΤβΗΗΗ 3aKJH0HaeTCH Β pa3padOTKe ΟΒΗΗΙξΟΒΟΓΟ clear-Ba c HB3KHM coflepxaHaeM cypBMH jyui η3γοτοβλθηεη pemena-THX raaoTUH.OK jvih khcjiothux cbhhhobhx aKKyMyjwTopoB co-TopuS ^ AET's released bucokoS ctokkootbio upothb odpaBOBamiH ro-panux τρβιΐξΐΐΗ NPN bkcokoíí Teraiepaiype jbitm η οληοβρθμθηηοHCKJEKHaeT kanamycin and HHTeodpa3OBaHae.
H3jroseHHe cvtuhocth H3odpeTeHHHH3jroseHHe cvtuhocth H3odpeTeHHH
HpHHHHOS: VyBOTBHTeJIBHOCTH CEJiaBa K 0Ópa30BaHHK) ΓΟρΗΗΠΧTpemnu hbjlsotch MeKBpHCTanjnraecKoe pacTpecKHBaHae, nponc-xozcainee npa 3οβηπι6ηηοη ckopocth oxjiaKfleHKH b HHTepBane3acTHBaBKH ÓJDJ3I, TeMnepaTypu cojmsyca cmíaBa; b θτομ 3a-Kjro-iaeTca τηπηηηοθ cbomctbo ληηηογο ciuiaBa. ropanne τρβ-ihmhh oópaayKTca npa 3tom npemviy^ecTBeHHO BGJie^cTBze orpa-ηηηθηηη ycajuca npn oxna^eHMM Ha τθχ μθοτθχ, Ha kotophx3acTHBaeT οοτβτοηηηη pacnaas. Sto npotíjieMa, npex&e Bcero,b cjiysac otjchbok, ημθιοπϊηχ pa3Hoe ceneHne h cjiosHyo κοΗφη- ·rypan^no· HosTOMy βηθ,πρθηηθ cmíaBa, ηυβοτεητ&πβηογο κ τρβ-upHooópa3OBaHHB npa HarpeBe, Tpedyei οηηηθηηη οκοροοτΗJEHTBH m/mJIH Η3ΜβΗβΗΗΗ ΤΘΧΗΟΛΟΓΗΗ JIHTBfí Η KOIÍCTpyKIíHH KOKU—Jieíi, HTO' CBH3aH0 C tíOJIBmHMH 3,aTpaTaMH. . ΠρΗΗΗΗΗ KanaHHH η HHTeodpa3OBaHHH, BejiyuíHe κ yxynnieHHio CHOCOÓHOCTH ΟΒΗΗΗΟΒΟΓΟ CIUiaBa Κ ρβΒΛΚΒΚΘ, βΐξβ Ηβ ΒΗΗΟΗΘΗΗ.OTnacTH 3τοτ HeflocTaTOK ο0μοηηθτοη odpasoBasaeM μθχθηη-neoKH ycToSHHBux ιυιβΗοκ okhch oaoBá. Jtpyrae κομποηθητηcroiaša τοχβ OKasuBaioT πολοηητθλβηοθ 'ra oTpnnaTejiBHoe bjhw-ΗΗβ Ha 3TOT θφφβΚΤ, T3K ΚΘΚ ΗΘΤ HCHOM 3aBHCHM0CTH OT CO-sepsamu ojioBa. B ocHOBy ΗβοόρβτβΗΗΗ noaioseHa 3aflana paapatíoTaTB cbhhhobhžcroiaB Ha da3e cBHHiia-cypBMu-MuinBHKa-eejieHa c hh3kmm cosepsa 245471 -5- ΗΕβΜ CypBMU jyw H3IOT0BJI6HIW ρβΙΠβΤΠβΤΗΧ UJiaCTHHOK ΟΒΗΗΕζΟ— .bux aKKyidyjiOTopoB. 3ia 3aj;ava coraacno H3oópeŤemii0 pemaeicH τθμ, hto paepa-.doran cmraB jma .οταοακα. penreraaTux wacTasoK jma CBEomo^bux aKKyidyjiHTopoB, coflepscamafiHpHHHHOS: VyBOTBHTeJIBHOCTH CEJiaBa 0Ópa30BaHHK K) ΓΟρΗΗΠΧTpemnu hbjlsotch MeKBpHCTanjnraecKoe pacTpecKHBaHae, nponc xozcainee NPA-3οβηπι6ηηοη ckopocth oxjiaKfleHKH b HHTepBane3acTHBaBKH ÓJDJ3I, TeMnepaTypu cojmsyca cmíaBa; b θτομ 3a-Kjro-iaeTca τηπηηηοθ cbomctbo ληηηογο ciuiaBa. anne anne anne anne anne anne anne anne anne anne anne anne anne anne anne anne anne anne anne anne pa pa pa pa pa pa pa pa Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha Ha. One hundred npotíjieMa, npex & e Bcero b cjiysac otjchbok, ημθιοπϊηχ pa3Hoe ceneHne h cjiosHyo κοΗφη- · digging-amino · HosTOMy βηθ, πρθηηθ cmíaBa, ηυβοτεητ & πβηογο κ τρβ-upHooópa3OBaHHB NPA HarpeBe, Tpedyei οηηηθηηη οκοροοτΗJEHTBH m / mJIH Η3ΜβΗβΗΗΗ ΤΘΧΗΟΛΟΓΗΗ JIHTBfí Η COH 2 O, CH 3 O 3, H 2 O C 1 H 5 HHMH 3, aTpaTaMH. . Π ΗΗΗΗΗ ana ana HT CH CH CH CH CH CH CH CH CH CH CH CH CH CH CH CH CH CH CH CH CH CH OC OC OC CH CH CH CH CH CH CH CH CH CH CH. Jtpyrae κομποηθητηcroiaša τοχβ OKasuBaioT οβ Ha 3TOT θφφβΚΤ, T3K ΚΘΚ CH HCHOM 3aBHCHM0CTH OT CO-sepsamu ojioBa. B ocHOBy ΗβοόρβτβΗΗΗ noaioseHa 3aflana paapatíoTaTB cbhhhobhžcroiaB Ha da3e cBHHiia-cypBMu-MuinBHKa-eejieHa c hh3kmm cosepsa 245471 -5- BΕβΜ CypBMU jyw H3IOT0BJI6HIW ρβΙΠβΤΠβΤΗΧ UJiaCTHHOK ΟΒΗΗΕζΟ—. 3ia 3aj; ava coraacno H3oópeŤemii0 pemaeicH τθμ, hto paepa-.doran cmraB jma .οταοακα. penreraaTux wacTasoK jma CBEomo ^ bux aKKyidyjiHTopoB, coflepscamafi
2, 0 λο 3,0 % cypiMU 0,02 ao 0,15 % Muui&HKa 0,015 λο 0,035 % cejreHa octqjibhoc -cbiíhsu, h b κοτοροΜ coaepaaHHe ojioBa orpamneHO λο 40,0020% (20 ppm),a coflepacamie Mejca orpaBHHeHÓ λο <0,0100 % (100 ppM>.2, 0 λο 3.0% cypiMU 0.02 and 0.15% Muui & HKa 0.015 λο 0.035% ceyreh octqjibhoc -cibium, hb κοτοροΜ coaepaaHHe ojioBa orpamne λο 40,0020% (20 ppm), and coflepacamie Mejca orpaBHHeHÓ λο < 0.0100% (100 ppM>.
KoHneHipanaa spyrax τϊππτηηηχ npuMeceft ciuiaBa κβκ cepedpa,BHCMyTa, ®ejie3a, hkk&jih, ixamca jionycKaeTca b npeji&nax,perjiawieHTapyeMux cTanKapiaMEt jmu λθηηογο mna cruiasoB. Πρημθρ ocymeoTBJíeHgg H3odpeieHHg H3 cmíaBa cjiesyiomero cocTasa:KoHneHipanaa spyrax τϊππτηηηχ npuMeceft ciuiaBa κβκ cepedpa, BHCMyTa, ejej3a, hkk & south, ixamca jionycKaeTca b npeji & nax, perjiawieHTapyeMux cTanKapiaMEt jmu λθηηογο mna cruiasoB. Π gg gg 3 3 3 3 3 3 3 3 3 3 3 3
2,7 % cyptMU 0,12 % Mum&HKa 0,0175 % cejieHa ocTajiBHoe ΟΒΗΗβΓζ 16 ppM ojxoBa 85 ppM MejBK (KOHpeHTpaiían ocTazmaux npHMeceft b οοοτβθτοτβηη o TTJI I4728)Ha jmTeiíHHX aBTOMaTax dmm Η3γοτοβπθηη oóhhhuq λβοΑηηθ pemer-KH TOJnUHHOfi 1,5 MM H 2,3 MM &JIH KHGJIOTHUX CBHHPpBHX aKKyMy-ΛΗΤΟρΟΒ. Ηβλθηκη asnamsa ώ. HZTeooópa3OBaaaa npa 3θληβκθ paciuaBa bΛΗΤβ&φ) φορΓΛΥ Ηβ HadJIKWaJinCL· PffSS npH BHCOKOS CKOPOCŤHjiHTBfl (13 - 14 λβοΕηηχ ρβωβτοκ β MHHyry); Ηβ HaffcnquajiooBotípa3OBaHHe ropjwnx ΤρβΙΙίΗΗ. 245471 ?2.7% 0.12% cyptMU Mum & HKA 0.0175% cejieHa ocTajiBHoe ΟΒΗΗβΓζ 16 ppm 85 ppm ojxoBa MejBK (b KOHpeHTpaiían ocTazmaux npHMeceft οοοτβθτοτβηη of TTJI I4728) Ha jmTeiíHHX aBTOMaTax dmm Η3γοτοβπθηη oóhhhuq λβοΑηηθ pemer-TOJnUHHOfi 1.5 mM KH H 2.3 MM & JIH KHGJIOTHUX CBHHPpBHX aKKyMy-ΛΗΤΟρΟΒ. Asβλθηκη asnamsa ώ. HZTeooópa3OBaaaa npa 3θληβκθ paciuaBa bΛΗΤβ & φ) φορΓΛΥ Ηβ HadJIKWaJinCL · PffSS npH BHCOKOS CKOPOCTHjiHTBfl (13-14 λβοΕηηχ ρβωβτοκ β MHHyry); Ηβ HaffcnquajiooBotípa3OBaHHe ropjwnx ΤρβΙΙίΗΗ. 245471?
I -6- ' Τθχπμ oópasoM, ciuias nojcnaeica otípatíoiKe c TaitoS xe buco- KOÍt ÍqpOH3BOflHTejEBHOCTKO K3K Η3ΒβΟΤΗΗβ CIDiaBH C BUČ OKEM CO- ΛθρχθΗΗβΜ cyptMU. Pemeriarae. iuacTKHKH ημθιοτ BucoKyro κόρ-I -6- 'Τθχπμ oópasoM, ciuias nojcnaeica í e e e e e BO BO BO BO ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID M M M M M M M M M M M M M. Pemeriarae. iuacTKHKH ημθιοτ BucoKyro κόρ-
p03H0HHyW CTOMKOCTB. Ιΐ3ΓΟΤΟΗ7ΙβΗΗΗβ H3 HHX QKKyMyjIHTOpU προΗΒΛΗΐοτ He3HaHHTejiÍHuft caMopá3pBB, a· Tarase HetíoJiLmy» CKHOHHOCTB K pa&HOXeHHK) BOflUJ φβΚΤΕΓΊβΟΚΗ Ηβ TpetíyiOT ΤβΧΗΗ- ΗβοκοΐΌ yxo.ua h cjiesoBaTejrBHO ημθιοτ OTjnnHue ποτρβόπτβΛΒ- cioie cB.oíicTBa. í i i | f i i 245471 -7- $QPMYJia HsodpeTeHHgp03H0HHyW CTOMKOCTB. Ιΐ3ΓΟΤΟΗ7ΙβΗΗΗβ H3 HHX QKKyMyjIHTOpU προΗΒΛΗΐοτ He3HaHHTejiÍHuft caMopá3pBB, and Taras · HetíoJiLmy »CKHOHHOCTB K pa & HOXeHHK) BOflUJ φβΚΤΕΓΊβΟΚΗ Ηβ TpetíyiOT ΤβΧΗΗ- ΗβοκοΐΌ yxo.ua h cjiesoBaTejrBHO ημθιοτ OTjnnHue ποτρβόπτβΛΒ- cioie cB.oíicTBa. í i i f i i 245471 -7- $ QPMYJia HsodpeTeHHg
Cbhhaobh2 ciwhb o hh3khm co^epsaííHeM cypiMu jpm H3roTOBJie-hhh pemeTqaTux unacTimoK ajw cbhhhobhx aKKyMyjLHTopoB, co-AepatáupriiCbhhaobh2 ciwhb hh3khm co ^ epsaííHeM cypiMu jpm H3roTOBJie-hhh pemeTqaTux unacTimoK ajw cbhhhobhx aKKyMyjLHTopoB, co-Aepatáuprii
ot 2,0 ao 3,0 % cypLMH ot 0,02 ao 0,15, % unashxua. ot 0,015. ao 0,035 % cejieHa ocTanj&Hoe csraeic, OTJrEraawtíioH τθμ, hto coAepaaime ojioBa orpaHtraeHo ao< 0,0020 % h coAepacaHHe μθαη orpamneHO ao < 0,0100 %. 245471 -β- Αηηοτβιχηη 3a^ana 3amnoxaeTca & paapaóoTKe crniasa Ha óaee CBZHna -cyptMH - MuinLHKa -cevieHa c bhcokoK ctoííkogtlk) πρ'οτηβTpeinHHooópa30BaHEW npz HarpeBe, He craioHsiomerocH npz paanHB-Ke κ KanaHHio z HHieodjpaBOBaHzio.rt 2.0 and 3.0% cypLMH rt 0.02 and 0.15,% unashxua. ot 0.015. and about 0.035% of ocTanj & Hoe csraeic, OTJrEraawtioH, ejoa, oepaaime ojioBa orpaHtraeHo and <0.0020% h coAepacaHHe μθαη orpamneHO, and <0.0100%. 245471 -b- Αηηοτβιχηη 3a ^ ana 3amnoxaeTca & paapaóoTKe crniasa Ha óaee CBZHna -cyptMH - MuinLHKa -cevieHa c bhcokoK ctoííkogtlk) πρ'οτηβTpeinHHooópa30BaHEW npz HarpeBe, He craioHsiomerocH npz paanHB-Ke κ KanaHHio of HHieodjpaBOBaHzio.
CnnaB. OTjnraaeToa τβΜ, hto oh co^epraT on? 2,0 λο 3,0 %. cypBMH 0,02 ao 0,15 % MHfflMKa, 0,015 «o0,035 % cejieHa, ooTajmjíoě OBHHen z zto coflepxcaHze ojiOBaorpauzseHO zo < 0,0020 % (20 ρρω) z Mejtz flo < 0,0100% (100 ppM). 245471CnnaB. OTjnraaeToa τβΜ, hto oh what ^ epraT he? 2.0 λο 3.0%. cypBMH 0.02 and 0.15% MHfflKKa, 0.015% 0.035% ciHa, ooTajmajo OBHHen z zto coflepxcaHze ojiOBaorpauzseHO of <0.0020% (20 ρρω) from Mejtz flo <0.0100% (100 ppM). 245471
• 3W• 3W
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD23805882A DD209360A3 (en) | 1982-03-11 | 1982-03-11 | ANTIMONARM BLELEGING |
Publications (2)
Publication Number | Publication Date |
---|---|
CS71683A1 CS71683A1 (en) | 1985-06-13 |
CS245471B1 true CS245471B1 (en) | 1986-10-16 |
Family
ID=5537194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS83716A CS245471B1 (en) | 1982-03-11 | 1983-02-02 | Lead alloy with low antimony content |
Country Status (3)
Country | Link |
---|---|
BG (1) | BG42284A1 (en) |
CS (1) | CS245471B1 (en) |
DD (1) | DD209360A3 (en) |
-
1982
- 1982-03-11 DD DD23805882A patent/DD209360A3/en not_active IP Right Cessation
-
1983
- 1983-02-02 CS CS83716A patent/CS245471B1/en unknown
- 1983-02-03 BG BG5956983A patent/BG42284A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS71683A1 (en) | 1985-06-13 |
BG42284A1 (en) | 1987-11-14 |
DD209360A3 (en) | 1984-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI843804A0 (en) | FOERFARANDE OCH ALKALI SOM TILLSATSMEDEL INNEHAOLLANDE KATALYSATOR FOER DIREKT SYNTES AV DIMETYL-DIKLORSILAN. | |
ES8205011A1 (en) | Silicone compositions for adhesion and method for adhering silicone rubber to a substrate | |
CA2381828A1 (en) | Binder composition | |
DK478179A (en) | ORGANOTINE MARKET ALCOHOL ESTERS AND ALCOXIDES CONTAINING SULPHIDE GROUPS | |
Wu et al. | Coal fly ash activated by NaOH roasting: Rare earth elements recovery and harmful trace elements migration | |
CS245471B1 (en) | Lead alloy with low antimony content | |
AU552558B2 (en) | Anti corrosive liquid detergents containing silicates | |
GB1130683A (en) | Improvements in silicone greases | |
IT8022481A0 (en) | IMPROVED ADHESION OF METALS TO SOLID SUBSTRATES. | |
EP0974559A3 (en) | Low melting point composite glass solder, its filler component, as well as its uses | |
EP0104012A3 (en) | Composition and method for simultaneously removing iron and copper scales from ferrous metal surfaces | |
ATE4438T1 (en) | COMPOSITIONS FOR INGESTION BY RUMINANTS, PROCESS FOR THEIR MANUFACTURE. | |
US1601232A (en) | Flux for enamel compositions | |
SE8203831L (en) | SET TO CLEAN A GAS CURRENT CONTAINING ZINKANGA | |
ES394951A1 (en) | Pesticidal compositions containing phosphoric acid esters and elemental sulphur | |
SU409979A1 (en) | ||
GB1242789A (en) | Process for preparing diorganozinc compounds from organobromide and organoiodide | |
JPS55140729A (en) | Solder glass | |
AU539856B2 (en) | Stabilization of aminomethylene phosphonic acids solutions against crystallisation | |
JPS559674A (en) | Sodium silicate adhesive | |
SU996353A1 (en) | Vacuum tube glass | |
SU833596A1 (en) | Glass solder | |
SU341769A1 (en) | ||
US2198932A (en) | Lead alloy | |
GB578187A (en) | Improvements in or relating to thermo-electric devices |